Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) EBIT Margin (2020 - 2025)

KORU Medical Systems has reported EBIT Margin over the past 11 years, most recently at 5.02% for Q4 2025.

  • Quarterly results put EBIT Margin at 5.02% for Q4 2025, up 1296.0% from a year ago — trailing twelve months through Dec 2025 was 7.23% (up 1193.0% YoY), and the annual figure for FY2025 was 7.23%, up 1193.0%.
  • EBIT Margin for Q4 2025 was 5.02% at KORU Medical Systems, up from 8.34% in the prior quarter.
  • Over the last five years, EBIT Margin for KRMD hit a ceiling of 143.11% in Q4 2022 and a floor of 55.2% in Q2 2022.
  • Median EBIT Margin over the past 5 years was 22.91% (2021), compared with a mean of 17.61%.
  • Biggest five-year swings in EBIT Margin: soared 17567bps in 2022 and later plummeted -17369bps in 2023.
  • KORU Medical Systems' EBIT Margin stood at 32.56% in 2021, then surged by 540bps to 143.11% in 2022, then crashed by -121bps to 30.58% in 2023, then skyrocketed by 41bps to 17.98% in 2024, then surged by 72bps to 5.02% in 2025.
  • The last three reported values for EBIT Margin were 5.02% (Q4 2025), 8.34% (Q3 2025), and 3.07% (Q2 2025) per Business Quant data.